Skip to content

Author

Feifan Ji

We have 1 of 5 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Jul 2026

Inhibition of DLX6 sensitizes lung adenocarcinoma to cisplatin via GPX4-dependent ferroptosis.

DLX6 is significantly upregulated in LUAD and offers a potential therapeutic target for sensitizing cisplatin treatment and improving chemotherapy resistance and highlights DLX6 as a key regulator of ferroptosis and cisplatin sensitivity in LUAD.

Zedong Sun, Minmin Zhou, Can Wang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.